BCM
BNTX icon

Bronte Capital Management’s BioNTech BNTX Stock Holding History

Bronte Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-77,292
Closed -$6.21M – 26
2024
Q2 		$6.21M Sell
77,292
-3,114
-4% -$285K 0.49% 23
2024
Q1 		$7.42M Buy
80,406
+57,042
+244% +$5.47M 0.61% 24
2023
Q4 		$2.47M Sell
23,364
-135
-0.6% -$13.6K 0.22% 27
2023
Q3 		$2.55M Hold
23,499
– – 0.26% 25
2023
Q2 		$2.54M Buy
23,499
+190
+0.8% +$21.4K 0.24% 29
2023
Q1 		$2.9M Buy
23,309
+16,558
+245% +$2.27M 0.34% 25
2022
Q4 		$1.01M Sell
6,751
-197
-3% -$30.3K 0.13% 26
2022
Q3 		$937K Hold
6,948
– – 0.12% 27
2022
Q2 		$1.04M Buy
6,948
+14
+0.2% +$2.14K 0.12% 31
2022
Q1 		$1.18M Buy
6,934
+232
+3% +$39K 0.1% 30
2021
Q4 		$1.73M Sell
6,702
-93
-1% -$25.5K 0.11% 27
2021
Q3 		$1.85M Sell
6,795
-4,168
-38% -$1.32M 0.14% 26
2021
Q2 		$2.45M Buy
+10,963
New +$2.07M 0.18% 20

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bronte Capital Management's BNTX Position: Q3 2024 in Review

Bronte Capital Management sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 77,292 shares — an estimated $6.21M sold.

Bronte Capital Management first reported a position in BNTX in Q2 2021 and held it in 13 quarters. The position peaked at $7.42M in Q1 2024. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Bronte Capital Management reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Bronte Capital Management sold 77,292 BioNTech shares in Q3 2024, an estimated $6.21M.
  • Bronte Capital Management first reported a position in BioNTech in Q2 2021 and held it in 13 quarters.
  • Bronte Capital Management's BioNTech position peaked at $7.42M in Q1 2024.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Bronte Capital Management's 13F filing for Q3 2024, filed 5 Nov 2024.